AlphaRx Retains Investor Relations Firm.Business Editors, Health/Medical Writers BIOWIRE2K RICHMOND HILL, Ontario--(BW HealthWire)--May 24, 2001 AlphaRx Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :AHRX), an innovative drug delivery company, is pleased to announce that it has retained NBT (NetBIOS over TCP/IP) Support for the NetBIOS protocol in Windows when running in a TCP/IP network. NBT supports legacy applications that use the NetBIOS protocol as well as NetBIOS name resolution, which converts NetBIOS names into IP addresses. Capital, Inc. to cover Investor Relations Investor relations The process by which the corporation communicates with its investors. and to increase investor awareness of the Company. Dale Shirley, Investor Relations Director of NBT Capital states, "We will help AlphaRx to reach out to a very large individual investor, institutional and broker dealer network and see that AlphaRx gets the attention and exposure it needs." NBT Capital will also provide financial advisory services advisory services advisory services provided to the public, in their capacity as owners and managers of animals, are an important part of veterinary science. They may be provided by government bureaux, by commercial companies who deal in pharmaceuticals or animals or animal to the Company, which include marketing the Company's story to its extensive financing sources and assist the Company to tap into the equity and debt financing Debt Financing When a firm raises money for working capital or capital expenditures by selling bonds, bills, or notes to individual and/or institutional investors. In return for lending the money, the individuals or institutions become creditors and receive a promise to repay market to fund the Company's long-term business activities. "We are pleased to engage NBT Capital to support the Company's development and implementation of a progressive IR program," said Michael Lee, President of AlphaRx. "We expect them to make a substantial contribution to a clear and candid dialogue with both the investment community and our existing shareholders." "NBT Capital will assist us as we reach out to new investors who share our optimism for AlphaRx's future, and whose interest and support are required as we work toward maximizing shareholder value," Mr. Lee added. About AlphaRx AlphaRx Inc. is a leading drug delivery company that develops and markets innovative therapeutic products based on its proprietary Bioadhesive Colloidal colloidal of the nature of a colloid. colloidal bath a bath containing gelatin, bran, starch or similar substances, to relieve skin irritation and pruritus. Dispersion drug delivery systems. These include: Colloidal Lipid Dispersion system for targeted delivery; Self-Emulsifying Controlled Release Tablet system for delivery of poorly water-soluble drugs; topical preparations; and biodegradable polymeric technologies for delivery of controlled release nutraceuticals and anti-microbial oral care products. FORWARD LOOKING STATEMENTS: This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the Company. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion